380 related articles for article (PubMed ID: 23145923)
1. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
Qin X; Yue Z; Sun B; Yang W; Xie J; Ni E; Feng Y; Mahmood R; Zhang Y; Yue L
Br J Pharmacol; 2013 Mar; 168(6):1294-312. PubMed ID: 23145923
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine and the transient receptor potential channel kinase(s).
Rohacs T
Br J Pharmacol; 2013 Mar; 168(6):1291-3. PubMed ID: 23186176
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine and FTY720 modulate pacemaking activity in interstitial cells of Cajal from mouse small intestine.
Nam JH; Kim WK; Kim BJ
Mol Cells; 2013 Sep; 36(3):235-44. PubMed ID: 23912597
[TBL] [Abstract][Full Text] [Related]
4. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.
Chubanov V; Mederos y Schnitzler M; Meißner M; Schäfer S; Abstiens K; Hofmann T; Gudermann T
Br J Pharmacol; 2012 Jun; 166(4):1357-76. PubMed ID: 22242975
[TBL] [Abstract][Full Text] [Related]
5. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
Vessey DA; Li L; Imhof I; Honbo N; Karliner JS
Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation.
Potteck H; Nieuwenhuis B; Lüth A; van der Giet M; Kleuser B
Cell Physiol Biochem; 2010; 26(1):67-78. PubMed ID: 20502006
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
9. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
Ter Braak M; Claas RF; Hegen B; Labocha S; Ferreirós N; Pfeilschifter J; Huwiler A; van Echten-Deckert G; Meyer Zu Heringdorf D
Biochem Pharmacol; 2011 Mar; 81(5):617-25. PubMed ID: 21163254
[TBL] [Abstract][Full Text] [Related]
10. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.
Berdyshev EV; Gorshkova I; Skobeleva A; Bittman R; Lu X; Dudek SM; Mirzapoiazova T; Garcia JG; Natarajan V
J Biol Chem; 2009 Feb; 284(9):5467-77. PubMed ID: 19119142
[TBL] [Abstract][Full Text] [Related]
11. TRPM7 regulates proliferation and polarisation of macrophages.
Schilling T; Miralles F; Eder C
J Cell Sci; 2014 Nov; 127(Pt 21):4561-6. PubMed ID: 25205764
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.
Sanchez T; Estrada-Hernandez T; Paik JH; Wu MT; Venkataraman K; Brinkmann V; Claffey K; Hla T
J Biol Chem; 2003 Nov; 278(47):47281-90. PubMed ID: 12954648
[TBL] [Abstract][Full Text] [Related]
13. The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors.
Payne SG; Oskeritzian CA; Griffiths R; Subramanian P; Barbour SE; Chalfant CE; Milstien S; Spiegel S
Blood; 2007 Feb; 109(3):1077-85. PubMed ID: 17008548
[TBL] [Abstract][Full Text] [Related]
14. The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I.
Koyrakh L; Roman MI; Brinkmann V; Wickman K
Am J Transplant; 2005 Mar; 5(3):529-36. PubMed ID: 15707407
[TBL] [Abstract][Full Text] [Related]
15. Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.
Nagaoka Y; Otsuki K; Fujita T; Uesato S
Biol Pharm Bull; 2008 Jun; 31(6):1177-81. PubMed ID: 18520051
[TBL] [Abstract][Full Text] [Related]
16. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
Egom EE; Mohamed TM; Mamas MA; Shi Y; Liu W; Chirico D; Stringer SE; Ke Y; Shaheen M; Wang T; Chacko S; Wang X; Solaro RJ; Fath-Ordoubadi F; Cartwright EJ; Lei M
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1487-95. PubMed ID: 21705677
[TBL] [Abstract][Full Text] [Related]
17. The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.
Xin C; Ren S; Eberhardt W; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2006 Jan; 147(2):164-74. PubMed ID: 16299553
[TBL] [Abstract][Full Text] [Related]
18. FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase.
Spijkers LJ; Alewijnse AE; Peters SL
Br J Pharmacol; 2012 Jun; 166(4):1411-8. PubMed ID: 22251137
[TBL] [Abstract][Full Text] [Related]
19. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720.
Hisano Y; Kobayashi N; Kawahara A; Yamaguchi A; Nishi T
J Biol Chem; 2011 Jan; 286(3):1758-66. PubMed ID: 21084291
[TBL] [Abstract][Full Text] [Related]
20. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]